Silverfin false false 31/03/2026 01/04/2025 31/03/2026 Dr C Crossley 06/02/2023 Dr E Hoque 06/02/2023 Dr C A Jack 06/02/2023 18 September 2026 The principal activity of the LLP during the financial year was that of a medical practice. SO307716 2026-03-31 SO307716 bus:Director1 2026-03-31 SO307716 bus:Director2 2026-03-31 SO307716 bus:Director3 2026-03-31 SO307716 2025-03-31 SO307716 core:CurrentFinancialInstruments 2026-03-31 SO307716 core:CurrentFinancialInstruments 2025-03-31 SO307716 core:Non-currentFinancialInstruments 2026-03-31 SO307716 core:Non-currentFinancialInstruments 2025-03-31 SO307716 core:LandBuildings 2025-03-31 SO307716 core:OtherPropertyPlantEquipment 2025-03-31 SO307716 core:LandBuildings 2026-03-31 SO307716 core:OtherPropertyPlantEquipment 2026-03-31 SO307716 2025-04-01 2026-03-31 SO307716 bus:FilletedAccounts 2025-04-01 2026-03-31 SO307716 bus:SmallEntities 2025-04-01 2026-03-31 SO307716 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 SO307716 bus:LimitedLiabilityPartnershipLLP 2025-04-01 2026-03-31 SO307716 bus:Director1 2025-04-01 2026-03-31 SO307716 bus:Director2 2025-04-01 2026-03-31 SO307716 bus:Director3 2025-04-01 2026-03-31 SO307716 core:OtherPropertyPlantEquipment 2025-04-01 2026-03-31 SO307716 2024-04-01 2025-03-31 SO307716 core:LandBuildings 2025-04-01 2026-03-31 SO307716 core:Non-currentFinancialInstruments 2025-04-01 2026-03-31 iso4217:GBP xbrli:pure

Company No: SO307716 (Scotland)

GILBERT ROAD MEDICAL GROUP LLP

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH THE REGISTRAR

GILBERT ROAD MEDICAL GROUP LLP

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026

Contents

GILBERT ROAD MEDICAL GROUP LLP

BALANCE SHEET

AS AT 31 MARCH 2026
GILBERT ROAD MEDICAL GROUP LLP

BALANCE SHEET (continued)

AS AT 31 MARCH 2026
Note 2026 2025
£ £
Fixed assets
Tangible assets 3 429,209 430,067
429,209 430,067
Current assets
Debtors 4 4,966 14,647
Cash at bank and in hand 5 156,943 100,545
161,909 115,192
Creditors: amounts falling due within one year 6 ( 40,600) ( 18,059)
Net current assets 121,309 97,133
Total assets less current liabilities 550,518 527,200
Creditors: amounts falling due after more than one year 7 ( 403,000) ( 403,000)
Net assets attributable to members 147,518 124,200
Represented by
Loans and other debts due to members within one year
Other amounts 100,018 76,700
100,018 76,700
Members' other interests
Members' capital classified as equity 47,500 47,500
47,500 47,500
147,518 124,200
Total members' interests
Loans and other debts due to members 100,018 76,700
Members' other interests 47,500 47,500
147,518 124,200

For the financial year ending 31 March 2026 the LLP was entitled to exemption from audit under section 477 of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008.

Members' responsibilities:

The financial statements of Gilbert Road Medical Group LLP (registered number: SO307716) were approved and authorised for issue by the members on 18 September 2026. They were signed on its behalf by:

Dr E Hoque
Designated member
Dr C A Jack
Designated member
Dr C Crossley
Designated member
GILBERT ROAD MEDICAL GROUP LLP

RECONCILIATION OF MEMBERS' INTERESTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026
GILBERT ROAD MEDICAL GROUP LLP

RECONCILIATION OF MEMBERS' INTERESTS (continued)

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026
EQUITY
Members' other interests
DEBT
Loans and other debts due to members less any amounts due from members in debtors
Total members' interests
Members' capital (classified as equity) Members' capital (classified as debt) Other amounts Total Total
£ £ £ £ £
Amounts due to members 121,856 0 121,856
Balance at 01 April 2024 48,000 121,856 0 121,856 169,856
Members' remuneration charged as an expense, including employment and retirement benefit costs 0 0 568,801 568,801 568,801
Members' interest after result for the financial year 48,000 121,856 568,801 690,657 738,657
Introduced by members 9,500 (9,500) 0 (9,500) 0
Revaluations (25,000) 0 0 0 (25,000)
Drawings 0 0 (589,457) (589,457) (589,457)
Transfers 15,000 (112,356) 97,356 (15,000) 0
Amounts due to members 0 76,700 76,700
Balance at 31 March 2025 47,500 0 76,700 76,700 124,200
Members' remuneration charged as an expense, including employment and retirement benefit costs 0 0 570,448 570,448 570,448
Members' interest after result for the financial year 47,500 0 647,148 647,148 694,648
Drawings 0 0 (547,130) (547,130) (547,130)
Amounts due to members 0 100,018 100,018
Balance at 31 March 2026 47,500 0 100,018 100,018 147,518

There are no existing restrictions or limitations which impact the ability of the members of the LLP to reduce the amount of Members' other interests.

GILBERT ROAD MEDICAL GROUP LLP

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026
GILBERT ROAD MEDICAL GROUP LLP

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Gilbert Road Medical Group LLP is a limited liability partnership, incorporated in the United Kingdom under the Limited Liability Partnerships Act 2000 and is registered in Scotland. The address of the LLP's registered office is 39 Gilbert Road, Bucksburn, Aberdeen, AB21 9AN, United Kingdom.

The financial statements have been prepared under the historical cost convention, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Limited Liability Partnerships Act 2000 as applicable to companies subject to the small companies regime and the requirements of the Statement of Recommended Practice Accounting by Limited Liability Partnerships issued in May 2024 (SORP 2024).

The financial statements are presented in pounds sterling which is the functional currency of the LLP and rounded to the nearest £.

Going concern

The members have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The members have a reasonable expectation that the LLP has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover represents amounts earned during the year from medical activities.

If, at the balance sheet date, completion of contractual obligations is dependent on external factors (and thus outside the control of the Limited Liability Partnership), then revenue is recognised only when the event occurs. In such cases, costs incurred up to the balance sheet date are carried forward as work in progress.

Employee benefits

Short term benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised as an expense when the LLP is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Defined contribution schemes
The LLP operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Taxation

The taxation payable on the partnership's profits is the personal liability of the members, although payment of such liabilities is administered by the partnership on behalf of its members. Consequently, neither partnership taxation nor related deferred taxation is accounted for in these financial statements. Sums set aside in respect of members' tax obligations are included in the balance sheet within loans and other debts due to members, or are set against amounts due from members as appropriate.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Land and buildings not depreciated
Plant and machinery etc. 15 - 33.3 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Non-financial assets
At each balance sheet date, the LLP reviews its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss.

If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

Where it is not possible to estimate the recoverable amount of an individual asset, the LLP estimates the recoverable amount of the cash-generating unit to which the asset belongs. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks.

Financial instruments

Financial assets and financial liabilities are recognised when the LLP becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the LLP after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the LLP intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are measured at transaction price including transaction costs.

Basic financial liabilities
Basic financial liabilities, including creditors are recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less.on-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Members' participation rights

Members' participation rights are the rights of a member against the LLP that arise under the members' agreement (for example, in respect of amounts subscribed or otherwise contributed, remuneration and profits).

Members’ participation rights in the earnings or assets of the LLP are analysed between those that are, from the LLP's perspective, either a financial liability or equity, in accordance with section 22 of FRS 102. A member’s participation rights including amounts subscribed or otherwise contributed by members, for example members’ capital, are classed as liabilities unless the LLP has an unconditional right to refuse payment to members, in which case they are classified as equity.

The profits are automatically divided as they arise or are determined, so that the LLP does not have an unconditional right to refuse payment, the amounts arising that are due to members are in the nature of liabilities. They should therefore be treated as an expense in the profit and loss account in the relevant year and, to the extent they remain unpaid at the year end, they should be shown as liabilities in the balance sheet. This will also be the case where there is a requirement to divide some or all profits but the basis upon which those profits are shared between individual members is not determined until after the balance sheet date, as a liability exists even if the identity of the recipients have not yet been determined.

All amounts due to members that are classified as liabilities are presented in the balance sheet within 'Loans and other debts due to members' and are charged to the Profit and Loss Account within 'Members' remuneration charged as an expense'. Amounts due to members that are classified as equity are shown in the balance sheet within 'Members' other interests'.

2. Employees

2026 2025
Number Number
Monthly average number of persons employed by the LLP during the year 25 25

3. Tangible assets

Land and buildings Plant and machinery etc. Total
£ £ £
Cost
At 01 April 2025 425,000 7,474 432,474
At 31 March 2026 425,000 7,474 432,474
Accumulated depreciation
At 01 April 2025 0 2,407 2,407
Charge for the financial year 0 858 858
At 31 March 2026 0 3,265 3,265
Net book value
At 31 March 2026 425,000 4,209 429,209
At 31 March 2025 425,000 5,067 430,067

4. Debtors

2026 2025
£ £
Trade debtors 4,894 14,478
Other debtors 72 169
4,966 14,647

5. Cash and cash equivalents

2026 2025
£ £
Cash at bank and in hand 156,943 100,545

6. Creditors: amounts falling due within one year

2026 2025
£ £
Trade creditors 40,600 18,059

7. Creditors: amounts falling due after more than one year

2026 2025
£ £
Bank loans (secured) 203,000 203,000
Other creditors 200,000 200,000
403,000 403,000

Bank loans are secured by a fixed and floating charge over the property and assets of the LLP.